Images (1)

Hydrocortisone

Author:Prof. Dr. med. Peter Altmeyer

Co-Autor:Hadrian Tran

All authors of this article

Last updated on: 10.04.2021

Dieser Artikel auf Deutsch

Synonym(s)

Hydrocortisone

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Weak non-halogenated glucocorticoid.

Half-lifeThis section has been translated automatically.

1,5 h

IndicationThis section has been translated automatically.

Status asthmaticus, allergic reactions, eczema; inflammatory, allergic and pruriginous dermatoses.

In addition, substitution therapy for adrenocortical insufficiency, acute adrenocortical insufficiency (e.g. Addisonian crisis) and adrenogenital syndrome (inhibition therapy to reduce ACTH release).

Systemic or topical administration for autoimmune diseases.

Dosage and method of useThis section has been translated automatically.

  • Ointment/cream: Apply a thin layer 1-3 times/day on the affected skin areas.

    Remember!

    Duration of application max. 8 weeks.
  • Systemic: 100-250 mg i.v.

Standard concentrationThis section has been translated automatically.

0.25-3% in ointments, creams and lotions.

Recipe(s)This section has been translated automatically.

PreparationsThis section has been translated automatically.

Ficortril, Dermoposterisan, Hydrogalene, Hydro-Wolff, Hydrocortisone Hoechst

Note(s)This section has been translated automatically.

Standard value: The reference range is between 171 and 536 nmol/l in the morning, between 64 and 337 nmol/l in the afternoon and < 138 nmol/l at night

Pathologically increased: Cushing's syndrome, obesity, anorexia nervosa, chronic alcoholism, severe acute and chronic general diseases, endogenous depression, hyperestrogenism, iatrogenic and paraneoplastic

Pathologically debased: Addison's syndrome

Authors

Last updated on: 10.04.2021

Author: Prof. Dr. med. Peter Altmeyer

Co-Autor: Hadrian Tran